ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Cosciens Biopharma Inc

Cosciens Biopharma Inc (0UGB)

1.6316
0.00
( 0.00% )
Updated: 19:00:00

Cosciens Biopharma Inc Financial Summary

The current 0UGB market cap is 7.92M. The company's latest EPS is USD -3.4086 and P/E is -1.14.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 532k3.87M5.26M5.64M4.5M
Operating Income -10.04M-5.96M-5.33M-20.99M-18.01M
Net Income -6.04M-5.12M-8.37M-22.73M-16.55M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 19.98M37.28M80.1M56.03M37.02M
Total Liabilities 22.44M24.07M27.12M20.25M18.82M
Total Equity -2.46M13.21M52.99M35.78M18.2M

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -10.73M-4.13M-8.58M-13.68M-17.12M
Investing 50k56k-658k-12k528k
Financing 3.89M20.47M51.04M-118k-151k
Market Cap 7.92M
Price to Earnings Ratio -1.14
Price to Sales Ratio 4.19
Price to Cash Ratio 0.55
Price to Book Ratio 1.04
Dividend Yield -

Share Statistics

Shares Outstanding 4.86M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change 0.01%
52 Week High 1.6316
52 Week Low 1.6313
Spread (Intraday) 0 (0%)

Company Info

Company Name Cosciens Biopharma Inc
Address aeterna zentaris inc
toronto, ontario M5K 1E7
Website https://www.zentaris.com/
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock